2019-11-15T00:25:35-06:00 2018-12-31 ERNST & YOUNG US LLP TWO NORTH CENTRAL AVENUE STE 2300 PHOENIX AZ 85004 990 2018-01-01 860098929 Vitalant % Tanya Perry VITA 4809464201 PO Box 1867 Scottsdale AZ 85252 Tanya Perry Executive VP, CFO 4806755506 2019-11-12 true PATRICK SHIELDS P01508556 6023223000 2019-11-13 70.162.82.4 86597020193195000005 2019-11-15 P C1FB216E02A8E0FF4B10C7F1585D3311BD03F0CC E94FFBFEF556666C2017410EF3F1708D338ADEDF 2018 2020-03-31 21:24:44Z David Green SAME AS C ABOVE Scottsdale AZ 85252 544033619 false 6167 X www.vitalant.org X 1943 AZ Blood Banking and Research. See Schedule O for more information. 17 17 5318 1200 0 190891 6856523 4284057 473676130 504847847 -6491485 15794648 4894051 7908346 478935219 532834898 255330 111900 0 0 277635124 275762059 0 0 0 264610139 271580639 542500593 547454598 -63565374 -14619700 580483291 487696681 258151201 187458381 322332090 300238300 X Blood Banking and Research. See Schedule O for more information. true false 433976286 111900 483824945 Blood Services Division - Blood Banking - See Schedule O 10344851 0 10737015 Vitalant Laboratories - See Schedule O 15671514 0 16484266 Vitalant Research Institute - See Schedule O 459992651 true true false false false false false false false true true true true false true true false true false false true false false false true true false true false true true false false false false false true false false false false true false false false false true true true false false true 819 0 true 5318 true true true true CJ false false false true true false false false false false false X 17 17 false false true false false false false true true false true true true true true true true true true true true true CA NM OH TN X Tanya Perry 4806755506 6210 E Oak St Scottsdale AZ 85257 X PATRICIA ABREGO-SANTUCCI TRUSTEE 2.0 1.0 X 23000 0 0 HEATHER J ALLEN MD TRUSTEE 3.0 1.0 X 37500 0 0 LINDA J BLESSING PHD TRUSTEE 3.0 1.0 X 27375 0 0 SUNNY P CHICO TRUSTEE 2.0 1.0 X 23000 0 0 ROBERT S COLE TRUSTEE 3.0 1.0 X 33875 0 0 WILLIAM A DITTMAN MD TRUSTEE 2.0 0.0 X 18500 0 0 BILL GATES TRUSTEE 2.0 1.0 X 28125 0 0 JOHN P HARNEY TRUSTEE 2.0 0.0 X 18500 0 0 MICHAEL H JONES TRUSTEE (THRU 11/18) 2.0 1.0 X 20500 0 0 JOHN S LEWIS TRUSTEE 3.0 1.0 X 37000 0 0 CLIFFORD LOWELL MD PHD TRUSTEE 2.0 0.0 X 22500 0 0 PIERRE NOEL MD TRUSTEE 2.0 0.0 X 25000 0 0 JAMES PETERSON TRUSTEE 2.0 1.0 X 22500 0 0 TERRI L PROCTOR TRUSTEE 2.0 1.0 X 22500 0 0 KATHLEEN S PUSHOR TRUSTEE/VICE CHAIR 3.0 0.0 X X 33625 0 0 JAMES R SCHRAITH TRUSTEE/SECRETARY/TREASURER 3.0 1.0 X X 40125 0 0 PAUL E STANDER MD TRUSTEE 2.0 1.0 X 23500 0 0 RON W WAECKERLIN MD TRUSTEE/CHAIR 3.0 0.0 X X 43750 0 0 GARY K WILDE TRUSTEE/VICE CHAIR (THRU 4/18) 3.0 0.0 X X 1250 0 0 DAVID GREEN PRESIDENT/CEO 55.0 1.0 X 690754 0 55265 TANYA PERRY EVP/CFO 40.0 15.0 X 347293 0 42361 BHAVI SHAH EVP/CLO, GENERAL COUNSEL 40.0 15.0 X 367776 0 36748 MARY BETH BASSETT EVP/CHIEF QUALITY OFFICER 55.0 0.0 X 329306 0 45018 ANTHONY BOBOS EVP/CHIEF INFORMATION OFFICER 55.0 0.0 X 324894 0 46643 MICHAEL BUSCH SVP/RESEARCH & SCIENTIFIC PROG 45.0 0.0 X 458381 0 45104 DIRK JOHNSON EVP/BLOOD SERVICES OPERATIONS 55.0 0.0 X 309439 0 33586 PETER MICHAELSON EVP/CHIEF PEOPLE OFFICER 55.0 0.0 X 309973 0 54542 ROBERT VAN TUYLE PRESIDENT, BLOOD SERVICES 55.0 0.0 X 418714 0 58254 RALPH VASSALLO EVP/CHIEF MEDICAL & SCIENTIFIC 55.0 0.0 X 421919 0 44855 HANY KAMEL VP, CORPORATE MEDICAL DIRECTOR 45.0 0.0 X 360529 0 49676 CHARLES WILCOX III DIVISION PRESIDENT, BLOOD CTR 0.0 45.0 X 349633 0 26534 KEVIN LAND VP, CLINICAL SERVICES 45.0 0.0 X 343277 0 36091 CHRISTOPHER GRESENS SENIOR CHIEF MEDICAL OFFICER 45.0 0.0 X 311628 0 39493 Anne Burtchaell DIVISION PRESIDENT, BLOOD CTR 0.0 45.0 X 311628 0 36041 SUSAN BARNES FORMER EVP/CFO 0.0 0.0 X 355600 0 0 LINDA MATTHEWS PRESIDENT, BIOCARE 0.0 55.0 X 480075 0 55718 J DANIEL CONNOR FORMER PRESIDENT/CEO 0.0 0.0 X 332923 0 0 7325867 0 705929 368 true true false CREATIVE TESTING SOLUTIONS 2424 W ERIER DRIVE TEMPE AZ 85282 LABORATORY TESTING 53905319 UPS PO BOX 894820 LOS ANGELES CA 90189 DELIVERY SERVICE 3453766 MAK SYSTEMS 2720 RIVER ROAD SUITE 225 DES PLAINES IL 60018 CONSULTANT 1708135 TOLIN MECHANICAL SYSTEMS 12005 E 45TH AVENUE DENVER CO 80239 Maintenance Service 1542423 SUNSERI ASSOCIATES 1930 G STREET SACRAMENTO CA 95811 MAINTENANCE SERVICE 1257926 50 261985 241122 3780950 2742355 4284057 BLOOD & COMPONENT SRV FEE 541900 417777110 417777110 Laboratory Services 621500 39020072 39020072 Plasma for Fractionation 541900 26725896 26725896 Research Contracts 541700 11899208 11899208 PHarmaceutical Products 446110 167806 167806 9257755 9257755 504847847 13462503 13462503 0 25660 25660 1221094 1221094 0 1221094 1221094 9494861 3781307 8317456 2626567 1177405 1154740 2332145 2332145 39521 261985 220764 -181243 -181243 28300 33934 -5634 -5634 0 0 0 Miscellaneous Income 900099 6848469 6848469 6848469 532834898 511696316 16854525 111900 111900 0 0 0 0 0 0 5649172 0 5649172 0 1224316 0 1224316 0 213308185 159171162 54137023 0 4899840 3241895 1657945 0 35249848 27983804 7266044 0 15430698 11360554 4070144 0 0 0 0 0 995636 0 995636 0 622133 0 622133 0 0 0 0 0 0 0 160223 0 160223 0 7086782 1516061 5570721 0 412974 412974 0 0 28219147 21515017 6704130 0 2719417 2400289 319128 0 0 0 0 0 24576552 21096189 3480363 0 16717948 14530669 2187279 0 0 0 0 0 0 0 0 0 1591049 0 1591049 0 0 0 19275576 11844065 7431511 0 2518256 2454591 63665 0 OPERATING & TESTING SUPPLIES 117790639 117790639 Donor Recognition & Promo 14728131 14728131 Pharm/Blood Prod Purchase 35845313 35845313 Income Tax 6863 6863 -1686000 13982535 -15668535 547454598 459992651 87461947 0 0 27877191 3097425 1745610 1253155 0 0 149394586 112422359 72450 47451 0 0 13677893 2601483 13818395 12979314 50123739 9633328 292805331 175531340 129260088 117273991 126161444 119447730 67751895 67751895 600000 40718395 0 0 0 470155 580483291 487696681 133153935 95842902 0 0 1994891 1360748 32122061 29198703 0 0 0 0 17655160 14580743 0 0 73225154 46475285 258151201 187458381 X 322230664 299931194 1426 207106 100000 100000 322332090 300238300 580483291 487696681 X -14619700 -11198446 0 0 0 3724356 X false true X true true true X 8365565 7622066 6845081 6856523 4934147 34623382 488608480 411975653 468181673 478677327 511696316 2359139449 0 0 0 496974045 419597719 475026754 485533850 516630463 2393762831 0 0 0 2393762831 4295796 3232549 2530890 3201381 4707735 17968351 334499 518513 1272996 0 0 2126008 4630295 3751062 3803886 3201381 4707735 20094359 0 0 501604340 423348781 478830640 488735231 521338198 2413857190 0.99167 0.99180 0.00833 0.00820 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 29958599 307107 -1807768 28457938 27130153 4135779 1307333 29958599 25097431 2032722 27130153 26960483 483 -561129 1302406 25097431 29650105 1268538 3958160 26960483 0.98920 0.00350 0.00730 false false 18164389 18164389 111890785 53111034 58779751 17436514 14977394 2459120 91055004 66735556 24319448 54258639 40707356 13551283 117273991 Investment in BioCare, Inc. 67751895 F 67751895 Investment in Canyon State Ins 500000 F Investment in HemeXcel 100000 F INVESTMENT IN CREATIVE TESTING 40118395 F 40718395 0 Line of Credit 24500000 Contributions Payable 21274528 Long Term Rent Set Up 674392 LT TENANT IMPROVEMENT ALLOWANCE 26365 46475285 X 0 0 0 0 0 0 0 0 0 0 0 0 SCHEDULE D, PART V, LINE 4 Vitalant's Board DESIGNATED endowment funds are reserved for the purposes of providing research funds to Vitalant's Research Institute to support the blood transfusion research efforts of that division. SCHEDULE D, PART X, LINE 2 At December 31, 2018, the Company evaluated whether it had uncertain tax positions that should be recognized or derecognized based on a 'more likely than not' threshold for tax positions taken or expected to be taken in a tax return, including those tax positions that would not be sustained upon examination in accordance with guidance related to ASC 740 'Accounting for Uncertainty in Income Taxes.' The tax years for the Company that are subject to audit by the IRS and state departments of revenue are generally the tax years ended December 31, 2015, through the current tax year except in certain states where the open tax years generally begin with the tax year ended December 31, 2014. As of December 31, 2018, the Company has not identified any significant uncertain tax positions that would require the recording of a tax liability. The Company does not anticipate a change in uncertain tax positions for the 12 months following the year ended December 31, 2018. As of December 31, 2018, the Company had no interest or penalties qualified for either recognition or disclosure in the financial statements. Central America and the Caribbean Program services Captive Insurance 6884372 6884372 6884372 true false true false false false Schedule F, Part I, Line 3, Column (F) THE ORGANIZATION USED THE ACCRUAL METHOD OF ACCOUNTING TO DETERMINE THE AMOUNT IN COLUMN (F). Epicurean gala 301506 261985 39521 38529 32375 6695 143165 0 301506 261985 39521 38529 32375 6695 143165 220764 -181243 28300 0 33658 276 true 1.00000 28300 0 33658 276 33934 -5634 WA true false true false 1.00000 Susan Polon 210 W Cataldo Ave Spokane WA 99201 false Jeffrey Bryant 1287 Employee/Independent X false true AABB 8101 Glenbrook Rd Bethesda MD 20814 362384118 501(c)(3) 75000 NBF/Cord Support Donations Charity Golf Sponsorship Flights for Life PO Box 26485 Phoenix AZ 85068 742453899 501(c)(3) 20000 0 DONATIONS HonorHealth 8125 N Hayden Scottsdale AZ 85258 742355411 501(c)(3) 8000 0 CHARITY GOLF SPONSORSHIP 3 SCHEDULE I, PART I, LINE 2 SPONSORSHIPS AND DONATIONS TO OTHER TAX-EXEMPT ENTITIES ARE MADE IN SUPPORT OF THEIR MISSIONS AND ARE MONITORED VIA THE GOVERNANCE PRACTICES OF THOSE ENTITIES. X X X X true true false false false false false true false DAVID GREEN PRESIDENT/CEO 610854 0 68200 0 11700 0 29500 0 25765 0 746019 0 0 0 TANYA PERRY EVP/CFO 330543 0 7150 0 9600 0 27122 0 15239 0 389654 0 0 0 BHAVI SHAH EVP/CLO, GENERAL COUNSEL 322776 0 34300 0 10700 0 11000 0 25748 0 404524 0 0 0 MARY BETH BASSETT EVP/CHIEF QUALITY OFFICER 295603 0 12736 0 20967 0 29500 0 15518 0 374324 0 10267 0 ANTHONY BOBOS EVP/CHIEF INFORMATION OFFICER 308474 0 6820 0 9600 0 14329 0 32314 0 371537 0 0 0 MICHAEL BUSCH SVP/RESEARCH & SCIENTIFIC PROG 412717 0 17511 0 28153 0 29500 0 15604 0 503485 0 18553 0 DIRK JOHNSON EVP/BLOOD SERVICES OPERATIONS 288299 0 10440 0 10700 0 11000 0 22586 0 343025 0 0 0 PETER MICHAELSON EVP/CHIEF PEOPLE OFFICER 273057 0 12083 0 24833 0 29500 0 25042 0 364515 0 14133 0 ROBERT VAN TUYLE PRESIDENT, BLOOD SERVICES 391074 0 16940 0 10700 0 29500 0 28754 0 476968 0 0 0 RALPH VASSALLO EVP/CHIEF MEDICAL & SCIENTIFIC 394161 17058 10700 29500 15355 466774 0 HANY KAMEL VP, CORPORATE MEDICAL DIRECTOR 324038 0 14154 0 22337 0 29500 0 20176 0 410205 0 12737 0 CHARLES WILCOX III DIVISION PRESIDENT, BLOOD CTR 321537 0 11462 0 16634 0 11000 0 15534 0 376167 0 7034 0 KEVIN LAND VP, CLINICAL SERVICES 328748 0 14529 0 0 0 11000 0 25091 0 379368 0 0 0 SUSAN BARNES FORMER EVP/CFO 0 0 0 0 355600 0 0 0 0 0 355600 0 12284 0 J DANIEL CONNOR FORMER PRESIDENT/CEO 0 0 0 0 332923 0 0 0 0 0 332923 0 24350 0 LINDA MATTHEWS PRESIDENT, BIOCARE 317012 0 115506 0 47557 0 29500 0 26218 0 535793 0 36857 0 CHRISTOPHER GRESENS SENIOR CHIEF MEDICAL OFFICER 300202 0 4226 0 7200 0 11000 0 28493 0 351121 0 0 0 Anne Burtchaell DIVISION PRESIDENT, BLOOD CTR 292155 0 9873 0 9600 0 11000 0 25041 0 347669 0 0 0 SCHEDULE J, PART I, LINE 4A SEVERANCE PAYMENTS WERE MADE TO THE FOLLOWING IN 2018: SUSAN BARNES - $343,316 J. DANIEL CONNOR - $308,574 THESE AMOUNTS ARE TAXABLE AND ARE INCLUDED IN SCHEDULE J, PART II, COLUMN (B)(III). SCHEDULE J, PART I, LINE 4B CERTAIN EMPLOYEES RECEIVED DISTRIBUTIONS FROM THE SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN DURING 2018 AS FOLLOWS: MARY BETH BASSETT - $10,267 MICHAEL BUSCH, MD - $18,553 HANY KAMEL, MD - $12,737 SUSAN BARNES - $12,284 J. DANIEL CONNOR - $24,350 CHARLES WILCOX III - $7,034 PETER MICHAELSON - $14,133 LINDA MATTHEWS - $36,857 THESE AMOUNTS WERE INCLUDED IN TAXABLE WAGES AND ARE REPORTED IN SCHEDULE J, PART II, COLUMN (B)(III) AND ALSO IN COLUMN (F) SINCE THESE AMOUNTS HAVE PREVIOUSLY BEEN REPORTED AS DEFERRED COMPENSATION ON A PRIOR FORM 990. THIS PLAN WAS FROZEN AS OF DECEMBER 31, 2011. SCHEDULE J, PART I, LINE 7 VITALANT HAS AN INCENTIVE BONUS PLAN FOR MANAGEMENT AND EXECUTIVES. AWARDS UNDER THE PROGRAM ARE AT THE DISCRETION OF THE BOARD OF TRUSTEES. THE PLAN MEASURES PERFORMANCE AGAINST MULTIPLE METRICS WHICH CARRY VARIOUS WEIGHTINGS, THE MOST HEAVILY WEIGHTED BEING QUALITY, SAFETY AND CUSTOMER SERVICE. TO ASSURE FINANCIAL STABILITY OF THE COMPANY, ONE OF THE METRICS IS ALSO A MEASUREMENT OF NET MARGIN FINANCIAL PERFORMANCE AS A PERCENT OF REVENUES. SCHEDULE J, PART II LINDA MATTHEWS IS THE PRESIDENT OF THE BIOCARE, A SUBSIDIARY OF VITALANT. BIOCARE PERFORMED WELL ABOVE ITS BUDGETED EXPECTATIONS AND, AS A RESULT, LINDA WAS GRANTED AN INCENTIVE BONUS. A California Municipal Finance Authority 201563466 2008-04-17 16895000 SEE PART VI false false false B Arizona Health Facilities Authority 860453292 2014-01-06 27005000 SEE PART VI false false false A 2450000 0 16895000 0 0 0 137100 0 0 16757900 0 0 2008 false false true true B 10560000 0 27005000 0 0 0 41114 0 0 26963886 0 0 2014 true false true true A false false false false 0 0.00000 0.00000 false false false true B false false false true false 0 0.00700 0.00700 false false false true A false false false true true true UNION BANK 13.3 false false false 0 false true B false false true false false false 0 false 0 false true A true B true . Schedule K, Part I, Line A, Column (F) PURCHASE OF REAL PROPERTY AND TO CONSTRUCT, INSTALL & FURNISH IMPROVEMENTS IN CALIFORNIA. Schedule K, Part I, Line B, Column (F) REFUNDING OF AHFA 2004 BOND ISSUE WHICH WAS USED FOR THE PURCHASE OF LAND AND TO CONSTRUCT AND EQUIP 11 BLOOD CENTERS IN VARIOUS STATES FOR THE PURPOSE OF RECRUITING, COLLECTING, PROCESSING AND DISTRIBUTING BLOOD PRODUCTS; REFUNDING OF ABAG 2002 BOND ISSUE USED TO CONSTRUCT A BLOOD CENTER IN SAN FRANCISCO, CA; AND, REFUNDING OF AHFA 1995 VARIABLE RATE BOND ISSUE USED TO CONSTRUCT AND EQUIP A NATIONAL BLOOD TESTING LABORATORY IN TEMPE, ARIZONA. SCHEDULE K, PART IV, LINE 2C, COLUMN A DATE OF REBATE COMPUTATION: APRIL 17, 2013 David Green officer House X 150000 47451 false true true 47451 X Recognition 540 2708009 COST/SELLING PRICE X Refreshment 30 10506 COST/SELLING PRICE X Other 14 23841 COST/SELLING PRICE false true false SCHEDULE M, PART I, COLUMN (B) THE ORGANIZATION IS REPORTING THE NUMBER OF CONTRIBUTIONS RECEIVED IN COLUMN (B). FORM 990, PART I, LINE 1 AND PART III, LINE 1 VITALANT EXISTS TO MAKE A DIFFERENCE IN PEOPLE'S LIVES BY BRINGING TOGETHER THE BEST PEOPLE, INSPIRING INDIVIDUALS TO DONATE BLOOD, PRODUCING A SAFE AND AMPLE BLOOD SUPPLY, ADVANCING CUTTING-EDGE RESEARCH AND EMBRACING CONTINUOUS QUALITY IMPROVEMENT. Vitalant, one of the nations oldest and largest nonprofit community blood service providers, supplies comprehensive transfusion medicine services to nearly 1,000 hospitals and health care partners for patients in need across 40 states. FOrm 990, Part III, Line 2 EFFECTIVE JANUARY 1, 2019 BERGEN COMMUNITY REGIONAL BLOOD CENTER ("BCRBC") MERGED INTO VITALANT. VITALANT IS THE SURVIVING ENITY. BCRBC CONTINUES TO OPERATE SERVICES AND PROGRAMS AS PREVIOUSLY, NOW AS AN INTEGRAL PART OF VITALANT. FORM 990, PART III, LINES 4A-D 4A) Blood Services Division - Blood Banking The primary purpose of the Blood Services Division (BSD) is to provide a safe and stable supply of blood and blood components to hospitals adn medical facilities. The strength of BSD is that is operates as local blood centers that are part of the community and yet has access to a large networked organization with all the advantages and efficiencies that are realized through standardization and economies of scale. BSD collects blood from volunteer donors, performs screening and testing on the donated blood, and processes the whole blood into blood components such as red cells platelets and plasma. Blood and blood components ar then stored and distributed to hospitals and other health care providers. 4B) Vitalant Laboratories (VL; formerly Blood Systems Laboratories) Vitalant Laboratories' staff of highly trained and experienced personnel provide support and expertise to hospitals, transfusion and transplant centers and other healthcare facilities for their transfusion medicine needs. VL operates three laboratories for (IRL) Immunohematology Reference Lab, (HLA) Histocompatibility Laboratory and (CTL) Cellular Therapy Laboratory in Phoenix. The members and affiliates of Vitalant operate additional laboratories in San Francisco, Denver, Spokane and San Bernardino. Together they solve some of the most complex immunohematologic compatibility cases and ensure life-saving blood and cellular therapy services to hospitals all across the United States.For healthcare facilities in central Arizona, VL also serves as a blood bank, providing complete transfusion services including patient compatibility testing and delivery. 4C) Vitalant Research Institute (VRI; formerly Blood Systems Research Institute) The Vitalant Research Institute carries out studies funded by extramural grants (NIH and other agencies) and well over $3.5-4.5M each year by Vitalant itself. VRI has historically been noted for contributions to infectious disease testing / monitoring, epidemiology / public policy, and selected non-infectious risks of transfusion. Recent research efforts include characterization of metabolic and genetic factors that influence red blood cell stability, as well as investigation of novel methods for platelet cryopreservation. A public service, VRIs research extends far beyond organizational development efforts, benefiting patients all over the US (and the world) as well as competing US blood centers, improving blood product quality, recipient safety, and the donor experience. VRI supports training programs for specialists in transfusion medicine and the development of epidemiology research scientists. VRI investigators published 94 peer-reviewed original research papers in 2018 along with many more reviews, editorials, book chapters and scientific meeting abstracts. Together, VRIs 10 investigators, 2 clinical investigators, 13 affiliated investigators, 8 core leaders, 6 administrative staff and ~55 scientists, technologists and post-docs have contributed to major discoveries in transfusion safety and efficacy. FORM 990, PART VI, LINE 1A The Executive Committee has the powers of the Board of Trustees between Board meetings, unless prohibited by law or the Articles of Incorporation. The Executive Committee is composed of 6 or more Trustees, including the Chair, Vice Chair, Secretary-Treasurer, and three or more Trustees selected by the Board of Trustees. FORM 990, PART VI, LINE 4 Effective September 24, 2018, Blood Systems, Inc. legally changed its name to Vitalant. Accordingly, Vitalants Articles of Organization and Amended and Restated Bylaws were amended to reflect this legal name change. FORM 990, PART VI, LINE 11B The Form 990 is reviewed by management, including confirmation of compensation disclosures against W-2 and 1099 reporting. A copy of the draft Form 990 and all schedules is supplied to all Board members prior to the meeting held to accept the returns. the W-2s and 1099s are available for Board review upon request. The paid preparer, Ernst & Young, and members of management review the Form 990 with the committees and are available for answering questions. Any comments from the Board are considered prior to filing with the IRS. FORM 990, PART VI, LINE 12C Each year, the Board of Trustees and senior management are required to sign and return a Conflict of Interest form to company counsel. Any conflicts disclosed are discussed in Executive Session with the Board's Audit Committee and resolved. In addition, in preparation for the Form 990 filing, the Trustees, Officers, and Key Employees identified are required to respond to a comprehensive Conflict of Interest and Family Relationship questionnaire. Any conflicts disclosed are discussed with the Board's Audit Committee and disclosed appropriately on the form 990. FORM 990, PART VI, LINES 15A AND 15B The Board of Trustees has a Compensation and Human Resource Committee whose purpose, among other things, is to hire an independent consulting firm once every 2-3 years to provide data on competitiveness of salaries and benefits for the CEO and other officers of the corporation. The members of the Human Resource and Compensation Committee of the Board are all independent trustees and include no members of management. The recommendations of the Committee are reviewed by the entire Board prior to approval. Compensation for these individuals is set and approved by the Board each year. the results of these discussions, reviews and approvals are documented in the Executive Session minutes of the Board meetings. This process was last completed in 2017. FORM 990, PART VI, LINE 19 Upon written request to the Chief Financial Officer, a copy of the Form 990 will be mailed to the requester. The Form 990 for current and past years is also posted on Guidestar for organizations to access. The governing documents and Conflict of Interest Policy are not made available to the public. The organization's combined financial statements are made available upon request. FORM 990, PART XI, LINE 9 PENSION EXPENSE OTHER THAN NET PERIODIC COST $ 3,724,356 ------------ TOTAL $ 3,724,356 Blood Bank San BernardinoRiverside Fdn PO Box 1429 San Bernardino CA 92402 208911074 Fundraising CA 501(c)(3) 12A-I BBSBRC true Blood Science Foundation 875 Greentree Road Parkway Ctr Pittsburgh PA 15220 251562715 Fundraising PA 501(c)(3) 12D-III-O ITXM true Canyon State Insurance Company PO Box 1085 113 S Church St GRAND CAYMAN CJ KY1-1102 981084327 Captive Insurance CJ VITALANT FOREIGN 7833080 27842076 1.00000 true BioCare Inc 6210 E Oak Street Scottsdale AZ 85257 813906720 Pharma AZ VITALANT C Corp 9473859 155722380 1.00000 true Transfusion Technology Inc 102 Chestnut Ridge Road Montvale NJ 07645 223494865 Inactive NJ BCRBC C Corp 0 0 true true false true false false false true true false false false true true false true true true true true BERGEN COMMUNITY REGIONAL BLOOD CENTER c 241122 ACCRUAL BERGEN COMMUNITY REGIONAL BLOOD CENTER g 15935156 ACCRUAL BERGEN COMMUNITY REGIONAL BLOOD CENTER h 117925 ACCRUAL BERGEN COMMUNITY REGIONAL BLOOD CENTER l 986312 ACCRUAL BERGEN COMMUNITY REGIONAL BLOOD CENTER q 240459 ACCRUAL BIOCARE INC l 3389843 ACCRUAL BIOCARE INC q 224652 ACCRUAL BLOOD BANK OF SAN BERNARDINO & RIVERSIDE G 10337131 ACCRUAL BLOOD BANK OF SAN BERNARDINO & RIVERSIDE H 2851833 ACCRUAL BLOOD BANK OF SAN BERNARDINO & RIVERSIDE L 1700351 ACCRUAL BLOOD BANK OF SAN BERNARDINO & RIVERSIDE q 617058 ACCRUAL CANYON STATE INSURANCE COMPANY r 5740768 ACCRUAL CENTRAL BLOOD BANK g 10986469 ACCRUAL CENTRAL BLOOD BANK h 265644 ACCRUAL THE INSTITUTE FOR TRANSFUSION MEDICINE l 7012743 ACCRUAL LIFESOURCE g 603643 ACCRUAL LIFESOURCE h 274196 ACCRUAL VIRGINIA BLOOD SERVICES g 1581085 ACCRUAL SCHEDULE R, PART II THERE ARE VARIOUS RELATED TAX-EXEMPT BLOOD BANKING ORGANIZATIONS THAT ARE INCLUDED IN GROUP EXEMPTIONS, AND THEREFORE, IN ACCORDANCE WITH THE FORM 990 INSTRUCTIONS ARE NOT REPORTED ON SCHEDULE R, PART II.